On August 4, 2023,OncoCyte Corporation promoted James Liu to Senior Director, Controller & Principal Accounting Officer. On that same date, the Company appointed Mr. Liu to the additional role of interim Principal Financial Officer. Mr. Liu will serve as interim Principal Financial Officer until such time as a Chief Financial Officer is appointed, or until his earlier resignation or removal.

Mr. Liu, age 28, previously served as the Company?s Manager of Securities and Exchange Commission Reporting & Compliance from July 2021 to July 2022, as interim Controller from July 2022 to September 2022 and as Controller & Principal Accounting Officer since July 2022. Prior to that, Mr. Liu was the Accounting Manager of Acacia Research Corporation, an opportunistic capital platform that identifies and acquires other businesses, from November 2020 to July 2021, and Senior Accountant at Gatekeeper Systems Inc. (?Gatekeeper Systems?), a provider of loss prevention solutions, from August 2019 to November 2020. Prior to joining Gatekeeper Systems, Mr. Liu served as Senior Assurance Associate at BDO USA, LLP, an accounting firm, from October 2016 to August 2019.

Mr. Liu holds a BASc degree from the University of California, San Diego, and is a Certified Public Accountant.